Custom Search

Sunday, May 24, 2020

Can Aspirin prevent disease progression in COVID 19 patients

Proposed use of Aspirin in treatment of COVID 19 blood clot formation and early recovery.

Novel Corona Virus 19, first infect throat and then go inside the lungs tissue and damage lungs endothelial tissue leading to endotheliitis and due to cytokine flare , lungs tissue is damaged to great extent, and it becomes life threatening due to formation of blood clots which occlude transfer of oxygen in lungs tissue.

Three important points in disease progression are
1. Positive & Infected symptoms yet to appear or may not show any symptoms.
2. Symptoms with fever.
3. Lung tissue damage, due to cytokine flair.

So to proper design a therapy to protect each stage need to design, by considering existing available drugs.

Use of Aspirin required to be urgently evaluated by clinical trial
Aspirin is Acetylsalicylate, Aspirin as anti-inflammatory to protect cytokine flair:
1) Aspirin is good anti inflammatory drug, that is it prevent prostaglandin synthesis by blocking enzyme cycloxiginase,  Prostaglandin is responsible for fever in covid patients so fever can also be managed with aspirin and paracetamol.

2) Aspirin has got antiplatelate aggregation activity, because of which it makes a very good blood thing and anti inflammatory as well as anti coagulant drug.This action of aspirin will provide protection to patients from rise in temperature, as well as it will act as anticoagulant and prevent formation of blood clots.

3) Aspirin is a prodrug, it breakdown in to salicylic acid, it eventually reduces PH of body fluid and the presence of salicylic acid molecule in blood will not support corona virus reproduction.
Even the sputum and mucus accumulated in lungs will bet dissolve faster and provide protective effect.

Therefore its need of time that Aspirin in lower or moderate dose is evaluated in treatment of COVID 19

Overall the effect of aspirin appears to be beneficial and it is required to be confirmed through clinical trails.

Use of aspirin to treat Lupus
How to prevent Novel Corona Virus infection by use of Povidone Iodine Cream 

No comments:

How to successfuly activate and receive our articles on pharmaceuticals by E-Mail

Dear readers if you wish to receive our articles on pharmaceutical automatically into your email Inbox , as and when we write a new article over this website, then follow these 3 simple steps.


1.You should write your Email ID in the box provided and push the subscribe button


2.Enter the text code that we show you in a small new browser window after you enter your email ID.

3.Log in to your email and Check our verification email sent by "FEEDBURNER" , there you should verify the link we send you by email.




Enter your email address get our articles by email whenever this website is updated





Delivered by FeedBurner

Join the list of our readers from Universities ,Research and
Development centers Pharmaceutical Companies from all over the world.


Pharma Research Regulatory Guidelines Website
Texas Dallas, TX 75211 US
Email: timesofpharma@gmail.com Website: http://pharmacistspharmajournal.org/
Copyright © 2008-2020 all rights reserve www.pharmacistspharmajournal.org